Stock Movers: Novartis, Soitec, Nordex (Podcast) | Stock Movers

By Bloomberg Podcasts

Community Score: 50% | 36 views | 1mo

0 community ratings: null thumbs up, null thumbs down

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Novartis shares fall as much as 3.9% after the Swiss pharma group’s potential blockbuster heart drug, pelacarsen, failed in a final-stage study. It’s the company’s second trial disappointment within a week, coming days after Novartis temporarily paused trials of an experimental cell therapy for autoimmune diseases. - Nordex shares rise as much as 8.8%, the most in over four months, after being upgraded to buy at BofA Global Research. Analysts said they see “significant” earnings upgrades ahead following a period of underperformance from the wind turbine company. - Soitec surges as much as 13%, the most since July 23, as the French chip material company lifted its revenue guidance for the second quarter of 2027, citing accelerating Photonics-SOI demand. The firm outlined expectations for full-year revenue in this segment to be 2.5x-3x the previous year’s level. See omnystudio.com/listener (https:

Tags: Business, Business News, Daily News, News, bloomberg, bloomberg news, business, finance, investing, investing news, markets, markets news, podcast, radio, stock, stock market, stocks, stocks podcast